Rintaro Noro
8PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 11, 2025
ACTN4 Gene Amplification and Actinin-4 Protein Expression for Osimertinib Efficacy in EGFR-Mutant NSCLC.Takehiro Tozuka, Rintaro Noro, Yutaka Naito
|Jun 28, 2024
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression.Naomi Onda, Shinji Nakamichi, Mariko Hirao
|Jun 20, 2022
Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer.Miwako Omori, Rintaro Noro, Masahiro Seike
|Jun 14, 2022
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report.Anna Hayashi, Shinji Nakamichi, Yukako Nakayama
|May 17, 2022
The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non-small cell lung cancer.Masamitsu Shimizu, Akihiko Miyanaga, Masahiro Seike
|Nov 30, 2021
Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.Rintaro Noro, Kazufumi Honda, Kengo Nagashima
Pageof 2
Frequent Collaborators
4 joint publications
Akihiko Miyanaga
2 joint publications
Kazufumi Honda
2 joint publications
Shinji Nakamichi
2 joint publications
Takehiro Tozuka
1 joint publications
Kakeru Hisakane
1 joint publications
Teppei Sugano
1 joint publications
Kengo Nagashima
1 joint publications
Noriko Motoi
1 joint publications
Natsuki Takano
1 joint publications
Yasuhiro Terasaki
